Daniel Eckler is a Senior Scientist at Novartis, where they lead early pipeline development and provide expertise in process development for AAV and Lentivirus Gene & Cell Therapies. Previously, they held several roles at Pfizer, including Sr. Associate Scientist, focusing on drug process development with an emphasis on oncology. Daniel earned a Bachelor of Science in Chemical Engineering from Worcester Polytechnic Institute and is currently pursuing a Master of Business Administration in Finance at Endicott College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices